GT200800282A - Procedimiento para hacer n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida y materiales de partida para la misma - Google Patents

Procedimiento para hacer n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida y materiales de partida para la misma

Info

Publication number
GT200800282A
GT200800282A GT200800282A GT200800282A GT200800282A GT 200800282 A GT200800282 A GT 200800282A GT 200800282 A GT200800282 A GT 200800282A GT 200800282 A GT200800282 A GT 200800282A GT 200800282 A GT200800282 A GT 200800282A
Authority
GT
Guatemala
Prior art keywords
methyl
propenamide
indol
phenyl
ethyl
Prior art date
Application number
GT200800282A
Other languages
English (en)
Inventor
Acemoglu Murat
Joginder S Bajwa
Parker David John
Slade Joel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38832681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200800282(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of GT200800282A publication Critical patent/GT200800282A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A PROCEDIMIENTO PARA HACER N-HIDROXI-3-[4-[[[2-(2-METIL-1H-INDOL-3-IL) ETIL]AMINO]METIL]FENIL]-2E-2-PROPENAMIDA Y MATERIALES DE PARTIDA PARA LA MISMA Y EL CUAL ES UN COMPUESTO UTIL COMO INHIBIDOR DE HISTONA-DESACETILASA EN ESTADOS PATOLOGICOS.
GT200800282A 2006-06-12 2008-12-10 Procedimiento para hacer n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida y materiales de partida para la misma GT200800282A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80452706P 2006-06-12 2006-06-12
US86787806P 2006-11-30 2006-11-30

Publications (1)

Publication Number Publication Date
GT200800282A true GT200800282A (es) 2009-03-09

Family

ID=38832681

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800282A GT200800282A (es) 2006-06-12 2008-12-10 Procedimiento para hacer n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida y materiales de partida para la misma

Country Status (32)

Country Link
US (2) US20090306405A1 (es)
EP (2) EP2032533B8 (es)
JP (2) JP5431926B2 (es)
KR (2) KR101493530B1 (es)
CN (4) CN102167678B (es)
AR (1) AR061296A1 (es)
AU (1) AU2007257883B2 (es)
BR (1) BRPI0712847A2 (es)
CA (1) CA2653657C (es)
CL (2) CL2007001691A1 (es)
DK (1) DK2032533T3 (es)
EC (1) ECSP088978A (es)
ES (2) ES2553255T3 (es)
GT (1) GT200800282A (es)
HK (2) HK1162029A1 (es)
HR (1) HRP20130798T1 (es)
IL (2) IL195211A (es)
IN (1) IN2015DN00910A (es)
JO (1) JO2900B1 (es)
MA (1) MA30513B1 (es)
MX (2) MX2008015898A (es)
MY (1) MY147576A (es)
NO (1) NO341870B1 (es)
NZ (1) NZ572707A (es)
PE (2) PE20080851A1 (es)
PL (1) PL2032533T3 (es)
PT (1) PT2032533E (es)
RU (1) RU2448090C2 (es)
TN (1) TNSN08507A1 (es)
TW (1) TWI395734B (es)
WO (1) WO2007146718A2 (es)
ZA (1) ZA200809490B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000004075A1 (it) 2020-02-27 2021-08-27 Flamma Spa Processo per la preparazione di panobinostat

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB146260A (en) 1918-07-11 1921-08-11 Elektro Osmose Ag A process for preparing proteids charged with immune substances
GB8531612D0 (en) * 1985-12-23 1986-02-05 Beecham Wuelfing Gmbh & Co Kg Compounds
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
AU2002237261A1 (en) 2001-01-09 2002-07-24 Novartis Pharma Gmbh Rapid method for screening compounds for in vivo activity
DK1443967T3 (da) 2001-11-06 2007-04-16 Novartis Ag Kombination af cyclooxygenase-2-inhibitor/histondeacetylaseinhibitor
MX2008015899A (es) * 2006-06-12 2009-04-01 Novartis Ag Procedimiento para hacer sales de n-hidroxi-3-[4-[[[2-(2-metil-1h- indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida.

Also Published As

Publication number Publication date
EP2032533B8 (en) 2013-12-11
US8536346B2 (en) 2013-09-17
JP2014058532A (ja) 2014-04-03
PL2032533T3 (pl) 2013-08-30
NO341870B1 (no) 2018-02-12
EP2394991B1 (en) 2015-09-23
CN103086944A (zh) 2013-05-08
CN101466674A (zh) 2009-06-24
KR20140117703A (ko) 2014-10-07
EP2032533A2 (en) 2009-03-11
CN102174008A (zh) 2011-09-07
RU2008151726A (ru) 2010-07-20
KR101493530B1 (ko) 2015-02-13
CL2007001691A1 (es) 2008-05-16
ES2553255T3 (es) 2015-12-07
CA2653657A1 (en) 2007-12-21
AR061296A1 (es) 2008-08-20
JP5809223B2 (ja) 2015-11-10
TWI395734B (zh) 2013-05-11
RU2448090C2 (ru) 2012-04-20
NZ572707A (en) 2011-12-22
IN2015DN00910A (es) 2015-07-10
MX2008015898A (es) 2009-01-12
PE20120221A1 (es) 2012-03-21
ES2416286T3 (es) 2013-07-31
HK1126759A1 (en) 2009-09-11
PT2032533E (pt) 2013-06-28
US20120010418A1 (en) 2012-01-12
IL233836A (en) 2017-05-29
US20090306405A1 (en) 2009-12-10
IL195211A (en) 2014-08-31
CN102167678A (zh) 2011-08-31
EP2032533B1 (en) 2013-04-03
PE20080851A1 (es) 2008-08-18
CL2010000973A1 (es) 2011-07-01
AU2007257883B2 (en) 2011-09-29
CA2653657C (en) 2015-10-27
BRPI0712847A2 (pt) 2012-08-07
KR101540194B1 (ko) 2015-07-28
MY147576A (en) 2012-12-31
TW200815345A (en) 2008-04-01
NO20090137L (no) 2009-03-03
EP2394991A1 (en) 2011-12-14
MA30513B1 (fr) 2009-06-01
IL233836A0 (en) 2014-09-30
IL195211A0 (en) 2009-08-03
WO2007146718A2 (en) 2007-12-21
MX366213B (es) 2019-07-01
HK1162029A1 (en) 2012-08-17
WO2007146718A3 (en) 2008-06-19
JP5431926B2 (ja) 2014-03-05
ZA200809490B (en) 2009-10-28
DK2032533T3 (da) 2013-07-01
KR20090015969A (ko) 2009-02-12
JO2900B1 (en) 2015-09-15
CN102167678B (zh) 2013-08-28
HRP20130798T1 (en) 2013-09-30
ECSP088978A (es) 2009-01-30
TNSN08507A1 (en) 2010-04-14
JP2009540008A (ja) 2009-11-19
AU2007257883A1 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
BRPI0809929A2 (pt) Gerenciamento do tempo de vida útil de objetos para pares nativos/gerenciados
GT200800279A (es) Sales de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida
DK1989206T3 (da) E1-aktiveringsenzymhæmmere
CY1112345T1 (el) Πολυμορφικη μορφη της 4-[3-(4-κυκλοπροπανιοκαρβονυλ-πιπεραζιν-1-καρβονυλ)-4-φθορο-βενζυλ]-2η-φθαλαζιν-1-ονης
BRPI0912778A2 (pt) composto de amida
SM201000108B (it) Composti e composizioni come inibitori di proteinachinasi
SMAP200900020A (it) Composti e composizioni come inibitori di proteinachinasi
SMAP200900031A (it) Composti e composizioni come inibitori di proteinachinasi
GT200800209A (es) Compuestos organicos
DK1848694T3 (da) Heterocykliske substituerede phenylmethanoner som inhibitorer af glycintransporter
DK2046740T3 (da) Forbindelser med CRTH2-antagonistisk virkning
EA200802383A1 (ru) Полиморфные формы n-гидрокси-3-[4-[[[2-(2-метил-1h-индол-3-ил)этил]амино]метил]фенил]-2e-2-акриламида
DE502008003324D1 (de) Heteroaryl-substituierte piperidine
MA32142B1 (fr) Forme cristalline de dérivés de phénylamino pyrimidine
BRPI0720547A2 (pt) Inibidores de metaloprotease derivada de heterocíclico
ATE509925T1 (de) Substituierte bicyclocarbonsäureamidverbindungen
CU20090141A7 (es) Compuestos 2-amino pirimidina
BRPI0921596A2 (pt) Compostos de 4-[2-(2-fluorofenoximetil) fenil] piperidina
ATE544769T1 (de) 2-(substituiertes amino)- benzothiazolsulfonamidverbindungen als hiv- protease-inhibitoren
DE602008003698D1 (de) Globaler nagelschraubenhaltender Schraubendreher
DE112007000837A5 (de) Hubkolbenmaschine
FR2901072B1 (fr) Alternateur
GT200800282A (es) Procedimiento para hacer n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida y materiales de partida para la misma
DE602007007761D1 (de) Microcode-Patch-Erweiterungsmechanismus
DE112007001177A5 (de) Geteiltes Schwungrad